Also known as: Wells Fargo
Wells Fargo & Company is an American multinational financial services company operating globally with tens of millions of customers. It traces its roots to 1852 and is listed on the NYSE under WFC.
The FDA informed uniQure that Phase 1/2 study data for AMT-130 in Huntington's disease is insufficient to support a biologics license application, recommending a prospective, randomized, double-blind, sham surgery-controlled study instead.
Multiple analysts have raised price targets on Praxis Precision Medicines, with Wolfe Research initiating coverage at $500 and Guggenheim increasing its target to $800, citing strong market potential for ulixacaltamide in essential tremor.
